Skip to content

Clinical trials

Terminated Anemia, Refractory, with Excess of Blasts trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Phase: Not applicable Status: Terminated Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20071
20121
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Indiana University1
Masonic Cancer Center, University of Minnesota1
Ottawa Hospital Research Institute1
University of California, San Francisco1
University of Rochester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts5
Leukemia, Myeloid, Acute4
Lymphoma, Mantle-Cell4
Multiple Myeloma4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hodgkin Disease3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.